Innovaderm Research Inc.
Pharmaceuticals
See how your profile stacks up against this role.
We compared the job requirements to your profile to show where you're strong and where you fall short.
Due to ongoing global expansion, Indero is looking to hire a Regulatory Affairs Specialist. In this position, you will be responsible for preparation and submission of part I and/or part II following EU CTR and other applications created within or outside of the company to ensure documentation comply with applicable regulations and guidelines and contractual timelines are met. You will provide leadership for assigned projects regarding all regulatory activities that lead to start up of clinical trials.
Responsibilities:
Education
Experience
Knowledge and skills
The work environment
At Indero, you will work with brilliant and driven professionals. Our values are collaboration, innovation, reliability and responsiveness. We offer a stimulating work environment and attractive advancement opportunities.
As a Regulatory Affairs Specialist you will be eligible for the following perks:
About Indero
Indero is a CRO specialized in dermatology and Rheumatology. Since its beginnings in 2000, our organization has benefited from a solid reputation for the quality of its research and services exceeding the expectations of its clients. Based in Montreal, Indero continues to grow and expand in North America and Europe.
Indero is committed to providing equitable treatment and equal opportunity to all individuals. As such, Indero will provide accommodations throughout the recruitment and selection process to applicants with disabilities, upon request.
Indero only accepts applicants who can legally work in Romania.
After you apply, unlock the direct contact details of the people who actually make the call. A quick follow-up makes you 5x more likely to land an interview.
Marcus Rivera
Chief Revenue Officer

Henry Schein

Medline Industries, LP
ICON plc

Tether.io

Horizon

Innovaderm Research Inc.

Innovaderm Research Inc.

Innovaderm Research Inc.